- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01654523
Awareness Enhancement and Monitoring Device for Treatment of Trichotillomania
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
DESCRIPTION (provided by applicant): The goal of the proposed research is to further refine and evaluate an inconspicuous, awareness- enhancement and monitoring device (AEMD) which will assist the treatment of trichotillomania (TTM). TTM is associated with significant impairments in social functioning and often has a profound negative impact on self- esteem and well being. Conservative estimates suggest that 0.6% percent of the US population, or about 1.8 million people, meet full diagnostic criteria for TTM and approximately 7.5 million US residents have significant hair pulling problems. Of those treated, 60% to 70% are wholly or partially refractory to standard behavioral and pharmacological treatments and could therefore potentially benefit from this device. Best practice treatment for TTM involves a form of behavioral therapy known as habit reversal therapy (HRT). HRT requires persons with TTM to be aware of their hair pulling behaviors, yet the majority of persons with TTM pull most of their hair outside of their awareness. HRT also requires TTM sufferers to record the frequency and duration of their hair pulling behaviors yet it is impossible for a person to monitor behaviors that they are unaware of. Our Phase I efforts have produced a prototype device (AEMD) that solves these two problems. The prototype AEMD signals the TTM sufferer if their hand approaches their hair, thereby bringing pulling-related behavior into awareness. The prototype AEMD also logs the time, date, duration, and user classification of hair pulling related events. Our published pilot study and subsequent investigations establish that the prototype AEMD successfully alerts TTM sufferers to pulling-related behaviors and monitors TTM-related behavior in a laboratory setting. With respect to technological innovation, this project has the potential to develop the first available miniaturized, wearable, patient interactive, real-time data collecting and proximity-sensing device that both alerts sufferers to the presence of mental illness symptoms as they occur and keeps track of the frequency and intensity of the problem. The patented technologies developed for the AEMD have the potential to be of great value for a range of other health/mental health conditions or industrial applications. Our overall Phase II aim is to further refine the AEMD and to evaluate its acceptance and utility when used in an open trial course of professionally-led habit reversal therapy. It is hypothesized that the AEMD will be enthusiastically accepted by TTM sufferers and their clinicians and that it will perform as designed during the clinical trial. The Phase II AEMD will include a bracelet(s)/watch to be worn on each wrist, another element to be placed at the rear base of the neck, and a pager-like alert device to be worn at the belt-line or in a pocket. The AEMD, if found to be useful and effective, has the potential to significantly reduce the symptoms of TTM and its associated functional impairments. The AEMD also has great potential to improve assessment and monitoring of TTM behaviors which could be invaluable to clinicians planning treatment and to researchers evaluating the efficacy of various treatment strategies.
We discovered that the electronic monitoring capability of the AEMD did not function properly. Therefore we cannot report time spent pulling using the electronic device. We relied on self-report instruments to assess the impact of the psychotherapy combined with with the device on the severity of trichotillomania.
Study Type
Enrollment (Actual)
Phase
- Phase 2
Contacts and Locations
Study Locations
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48109
- University of Michigan
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Must have active hair pulling over the month prior to enrollment
- Must have noticeable hair loss
- Must experience significant distress related to Trichotillomania
- Must primarily pull from the head area
- Subjects taking medications will be included
- Must be able to read/write English
Exclusion Criteria:
- Current substance use diagnosis
- Chronic neurological disorder (other than chronic tics)
- Mental retardation
- Schizophrenia and other psychotic disorders
- Bipolar I disorder
- Prominent suicidal/homicidal ideation with imminent risk
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Treatment arm
Open trial with no randomization
|
Awareness Enhancement and Monitoring Device for Treatment of Trichotillomania
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mean Change in Massachusetts General Hospital Hairpulling Scale Baseline to Post-treatment
Time Frame: Baseline to post treatment; typically over 9 weeks
|
Measures severity of trichotillomania.
Total score ranges from 0 (none) to 28 (severe).
Mean change is determined by score at baseline minus score after treatment.
|
Baseline to post treatment; typically over 9 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Joseph A Himle, PhD, University of Michigan
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HUM00050426
- 2R42MH077362-02 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Trichotillomania
-
Johns Hopkins UniversityRecruitingTrichotillomania | Trichotillomania (Hair-Pulling Disorder) | Hair PullingUnited States
-
University of ChicagoNot yet recruitingTrichotillomania (Hair-Pulling Disorder) | DermatillomaniaUnited States
-
University of ChicagoCompletedTrichotillomania (Hair-Pulling Disorder) | DermatillomaniaUnited States
-
University of ChicagoRecruitingTrichotillomania (Hair-Pulling Disorder) | Skin-PickingUnited States
-
American UniversityCompletedTrichotillomania (Hair-Pulling Disorder) | Skin-PickingUnited States
-
Yale UniversityNeurocrine BiosciencesRecruitingTrichotillomania (Hair-Pulling Disorder)United States
-
HabitAware Inc.National Institute of Mental Health (NIMH); Marquette UniversityCompletedTrichotillomaniaUnited States
-
University of Wisconsin, MilwaukeeCompleted
-
University of PennsylvaniaNational Institute of Mental Health (NIMH)CompletedTrichotillomaniaUnited States
-
University of Sao PauloCompleted
Clinical Trials on Awareness Enhancement and Monitoring Device for Treatment of Trichotillomania
-
Umeå UniversityVästernorrland County Council, Sweden; Västerbotten County Council, SwedenRecruitingDepressive Disorder | Depression in Adolescence | Dysthymia and Chronic DepressionSweden
-
Case Western Reserve UniversityCompletedBipolar DisorderUnited States
-
Parc de Salut MarInstituto de Salud Carlos IIINot yet recruitingDepression | Suicide, Attempted | SuicideSpain
-
Home Skinovations Ltd.CompletedClinical and Usability Study to Determine Safety and Efficacy of the Clear Device for Acne TreatmentMonitor Acne Lessions Count Reduction as Result of Usinfg the DeviceCanada
-
Rush University Medical CenterWayne State UniversityRecruitingBack Pain | Chronic Pain | Neck PainUnited States
-
InvasixCompletedFacial Wrinkles and Rhytides ReductionCanada
-
Chang Gung Memorial HospitalCompleted
-
University Medical Center GroningenUniversity of Groningen; Universitas Sebelas Maret; University of Passau; Health... and other collaboratorsCompletedCardiovascular Diseases | Hypertension | Diabetes Mellitus, Type 2Vietnam
-
International Centre for Diarrhoeal Disease Research...Bill and Melinda Gates Foundation; Salu Design GroupRecruitingHypertension, Pregnancy-Induced | Hypertension in Pregnancy | Hypertension, Essential Hypertension | Hypertension; Pre-EclampsiaBangladesh